Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04754191 |
Title | Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer (ENCORE) |
Acronym | ENCORE |
Recruitment | Recruiting |
Gender | male |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University of Utah |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Huntsman Cancer Institute | RECRUITING | Salt Lake City | Utah | 84112 | United States | Details |